Categories
Market Reports News

Peripheral Artery Disease Market Analysis by Automation Type and Applications, Industry Growth Factors and Business Forecast 2023

Global Peripheral Artery Disease Market: Information By Treatment Type (Devices (Angioplasty Balloon, Angioplasty Stents (Stenting), Catheters, Plaque Modification Devices (Atherectomy), Hemodynamic Flow Alteration Devices, Others), Drugs (Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs)) By End User (Hospitals and Clinics, Ambulatory Surgery Centers and others) – Forecast till 2025

Market Highlights

Global Peripheral Artery Disease Market is estimated to be valued at USD 23,624.01 Million by 2025 and is expected to register a CAGR of 4.84% during the forecast period.

Peripheral artery diseases (PAD) are the diseases of the blood vessels located outside the brain and heart. PAD occurs when plaque builds up in the arteries that carry blood to the head, organs, and limbs. Factors such as rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral artery diseases, along with increasing product approvals, are driving the growth of the peripheral artery disease market. Additionally, rising cases of diabetes are also driving the growth of the Peripheral Artery Disease Market. However, product recalls and failures are hampering the market growth.

Get Sample Report at https://www.marketresearchfuture.com/sample_request/1540

Key Players

Market Research Future (MRFR) recognizes Koninklijke Philips NV (Netherlands), B. Braun Melsungen AG (Germany), Cook (US), Medtronic (Ireland), Bayer AG (Germany), Boston Scientific Corporation (US), Becton, Dickinson, and Company (BD) (US), Terumo Medical Corporation (Japan ), Biotronik (Germany), Cardinal Health (US) as the Key Players in the Global Peripheral Artery Disease Market.

Segment Analysis

The Global Peripheral Artery Disease Market has been segmented on the basis of Treatment Type and End User. The market, based on treatment type, has been segmented into devices, and drugs. Devices are further segmented into angioplasty balloon, angioplasty stents (stenting), catheters, plaque modification devices (atherectomy), hemodynamic flow alteration devices, and others. Drugs are further sub-segmented into lipid-lowering drugs, blood pressure-lowering drugs, glucose regulating drugs, and blood clot preventing drugs. The global peripheral artery disease market, by end-user, has been categorized as hospitals and clinics, ambulatory surgery centers, and others.

Regional Analysis

Geographically, the global peripheral artery disease market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. As per MRFR analysis, the Americas was the largest market for peripheral artery disease in 2018 and is expected to remain dominant during the review period. The growth of the Americas is due to the high prevalence rate of diabetes, rising healthcare expenditure, and increasing cases of obesity. Additionally, constantly changing lifestyle habits such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity are making individuals more susceptible to peripheral artery disease and is driving the market growth. For instance, according to the American Heart Association, peripheral artery disease (PAD) affects over 8.5 million Americans yearly.

Additionally, the American Diabetes Association, in 2015, stated that 30.3 million Americans, or 9.4% of the population, had diabetes. Moreover, USD 327 billion were spent in the US in 2017 for diabetes

Europe would follow the Americas in terms of value during the forecast period. The European market is expected to register a sturdy growth rate during the forecast period due to rising cardiovascular disorders and increasing cigarette smoking population. Additionally, the rising older population in the European Union is driving the growth of the peripheral artery disease market in Europe.

Asia-Pacific is expected to represent the highest market growth potential over the forecast period due to the growing patient pool and increasing technological advancements. The fast growth of the Asia-Pacific region is due to the increasing per capita income along with government initiatives to enhance the quality of healthcare and rising diabetes being the major concern in this region

The Middle East and Africa are expected to represent a modest market growth from 2019 to 2025. The Middle East would hold a substantial market share over the assessment period due to increasing obesity issues, rising initiatives by governments to improve patient care, and favorable reimbursement policies

For More See Healthcare Related Reports:

https://www.abnewswire.com/report.php?pcode=293227

https://www.abnewswire.com/report.php?pcode=293035

https://www.abnewswire.com/report.php?pcode=292856

https://www.abnewswire.com/report.php?pcode=292698

https://www.abnewswire.com/report.php?pcode=292550

https://www.abnewswire.com/report.php?pcode=292318

https://www.abnewswire.com/report.php?pcode=292081

https://www.abnewswire.com/report.php?pcode=291884

https://www.abnewswire.com/report.php?pcode=291739

Regional Analysis

The Asia Pacific, due to a high concentration of developing economies has a 43.7% share of the market making it the market leader by regional assessment. Investments in technological advancements and state of the art medical machinery are augmenting market growth. Moreover, The region includes South Korea which is a highly popular destination for cosmetic procedures. The APAC is expected to grow at a highly promising CAGR of 22% during the forecast period. Eastern and Central Europe also represent an important regional segment which is growing rapidly and is expected to establish itself as a medical tourism destination over the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]

https://thedailychronicle.in/